Biohaven licenses IgG degrader portfolio to Ono for $100M
Tweet Send to a Friend
Biohaven Ltd. (NYSE: BHVN) has entered into a licensing agreement with Ono Pharmaceutical Co., Ltd. (TYO: 4528), granting Ono an ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE




